HCT - In A Nutshell - KJ, page-77

silly question to waste their time IMO. Mgt can control companies activities and operations. Not the SP.

my list of questions would be:
1) when is a revised investor overview expected to be released to ASX
2) what is anticipated production capacity for Natshield targeted volume within UK. And when does US production expect to hit the previous stated 1m per month scaled capacity
3) are there any plans for South American launch of Natshield. What are the most likely other geographies in near term
4) what volume of nasel balm production is anticipated in US
5) what is the strategy for low GI pasta global distribution and are any of the Natshield relationships helping accelerate
6) are other companies in discussion regarding 80less sugar
7) are any active discussions occurring on Cannaboids